OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 122 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $11,741,000 | +2.2% | 2,372,000 | +61.7% | 0.16% | -6.0% |
| Q1 2015 | $11,487,000 | -2.1% | 1,467,000 | -24.3% | 0.17% | +5.0% |
| Q4 2014 | $11,738,000 | +2.6% | 1,937,000 | -27.8% | 0.16% | -12.6% |
| Q3 2014 | $11,435,000 | -31.1% | 2,684,300 | 0.0% | 0.18% | -23.4% |
| Q2 2014 | $16,589,000 | -4.9% | 2,684,300 | 0.0% | 0.24% | -30.3% |
| Q1 2014 | $17,448,000 | +93.1% | 2,684,300 | +67.2% | 0.34% | +83.4% |
| Q4 2013 | $9,036,000 | +54.9% | 1,605,000 | +68.9% | 0.19% | +55.8% |
| Q3 2013 | $5,833,000 | +4.9% | 950,000 | 0.0% | 0.12% | +12.1% |
| Q2 2013 | $5,558,000 | – | 950,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 525,000 | $2,956,000 | 1.06% |
| First Light Asset Management, LLC | 170,804 | $962,000 | 0.82% |
| PFM Health Sciences, LP | 5,047,119 | $28,415,000 | 0.57% |
| Rhenman & Partners Asset Management AB | 250,000 | $1,408,000 | 0.55% |
| NEA Management Company, LLC | 1,935,300 | $10,896,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 544,779 | $3,067,000 | 0.43% |
| APEX CAPITAL, LLC | 1,000,000 | $5,630,000 | 0.37% |
| Partner Investment Management, L.P. | 240,221 | $1,352,000 | 0.31% |
| Hudson Bay Capital Management LP | 1,002,405 | $5,644,000 | 0.23% |
| BAILARD, INC. | 243,300 | $1,370,000 | 0.22% |